Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Even a 510 % reduction in body weight can restore ovulation in women with obesity or PCOS
These effects make GLP-1 a powerful tool in managing type 2 diabetes and supporting weight loss
Eli Lilly submitted the orforglipron NDA to the FDA in Q1 2026 following ATTAIN Phase 3 trial data showing 14.7% body weight reduction at 45mg positioning the worlds first oral small molecule GLP-1 receptor agonist for obesity for anticipated FDA approval in late 2026 or 2027
Before the carbohydrates
US$ 22.93
US$ 27.42
US$ 21.32
US$ 25.96
US$ 25.60
US$ 25.06
US$ 23.24
US$ 29.51
